AUG 10, 2026 · JOURNAL ARTICLE
Targeting the ERO1A–PDIA1 redox axis in triple-negative breast cancer with AI-designed minibinders
Cell Death Discovery
Early-stage mechanistic work using AI-designed protein tools to target a redox pathway in TNBC, demonstrating proof-of-concept in vitro and in cell culture without efficacy data in living organisms or patients.
Reported
Top-scoring candidates selected8
Minibinders with demonstrated dir…3